Bellevue Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,694,064
| Closed | -$14M | – | 147 |
|
|
2025
Q1 | $14M | Sell |
9,694,064
-250,000
| -3% | -$461K | 0.31% | 63 |
|
|
2024
Q4 | $21.9M | Hold |
9,944,064
| – | – | 0.42% | 58 |
|
|
2024
Q3 | $16.4M | Hold |
9,944,064
| – | – | 0.27% | 78 |
|
|
2024
Q2 | $22.1M | Hold |
9,944,064
| – | – | 0.36% | 68 |
|
|
2024
Q1 | $26.7M | Buy |
9,944,064
+5,739,800
| +137% | +$13.9M | 0.41% | 71 |
|
|
2023
Q4 | $12.6M | Hold |
4,204,264
| – | – | 0.19% | 83 |
|
|
2023
Q3 | $4.12M | Sell |
4,204,264
-4,000
| -0.1% | -$5.79K | 0.07% | 103 |
|
|
2023
Q2 | $5.85M | Hold |
4,208,264
| – | – | 0.08% | 100 |
|
|
2023
Q1 | $6.69M | Sell |
4,208,264
-122,000
| -3% | -$630K | 0.1% | 99 |
|
|
2022
Q4 | $27M | Buy |
4,330,264
+105,000
| +2% | +$751K | 0.36% | 74 |
|
|
2022
Q3 | $28.3M | Sell |
4,225,264
-10,000
| -0.2% | -$68.7K | 0.41% | 65 |
|
|
2022
Q2 | $26.9M | Sell |
4,235,264
-63,900
| -1% | -$362K | 0.38% | 69 |
|
|
2022
Q1 | $19.9M | Sell |
4,299,164
-220,000
| -5% | -$944K | 0.23% | 93 |
|
|
2021
Q4 | $22.6M | Hold |
4,519,164
| – | – | 0.23% | 99 |
|
|
2021
Q3 | $54.5M | Hold |
4,519,164
| – | – | 0.55% | 58 |
|
|
2021
Q2 | $95.6M | Buy |
4,519,164
+530,000
| +13% | +$12.8M | 0.93% | 36 |
|
|
2021
Q1 | $112M | Sell |
3,989,164
-1,149,287
| -22% | -$33.9M | 1.18% | 27 |
|
|
2020
Q4 | $134M | Sell |
5,138,451
-327,264
| -6% | -$9.8M | 1.53% | 20 |
|
|
2020
Q3 | $203M | Buy |
5,465,715
+162,580
| +3% | +$6.44M | 2.81% | 8 |
|
|
2020
Q2 | $272M | Buy |
5,303,135
+265,245
| +5% | +$11.1M | 3.85% | 5 |
|
|
2020
Q1 | $159M | Buy |
5,037,890
+512,880
| +11% | +$27.1M | 3.08% | 6 |
|
|
2019
Q4 | $270M | Buy |
4,525,010
+283,549
| +7% | +$12.7M | 4.28% | 5 |
|
|
2019
Q3 | $155M | Buy |
4,241,461
+184,050
| +5% | +$7.29M | 2.89% | 8 |
|
|
2019
Q2 | $189M | Buy |
4,057,411
+3,561,864
| +719% | +$167M | 3.22% | 6 |
|
|
2019
Q1 | $19.9M | Buy |
495,547
+43,575
| +10% | +$1.95M | 1.09% | 27 |
|
|
2018
Q4 | $20.8M | Buy |
451,972
+60,120
| +15% | +$2.9M | 1.43% | 20 |
|
|
2018
Q3 | $17.4M | Buy |
391,852
+78,332
| +25% | +$3.6M | 1.1% | 29 |
|
|
2018
Q2 | $12.3M | Buy |
313,520
+140,800
| +82% | +$7.11M | 1.05% | 35 |
|
|
2018
Q1 | $12.5M | Buy |
172,720
+164,920
| +2,114% | +$12.1M | 1.24% | 32 |
|
|
2017
Q4 | $514K | Sell |
7,800
-200
| -3% | -$10.8K | 0.05% | 123 |
|
|
2017
Q3 | $401K | Hold |
8,000
| – | – | 0.04% | 130 |
|
|
2017
Q2 | $370K | Sell |
8,000
-24,000
| -75% | -$883K | 0.04% | 130 |
|
|
2017
Q1 | $1.13M | Sell |
32,000
-8,000
| -20% | -$183K | 0.15% | 98 |
|
|
2016
Q4 | $501K | Hold |
40,000
| – | – | 0.1% | 110 |
|
|
2016
Q3 | $554K | Hold |
40,000
| – | – | 0.1% | 114 |
|
|
2016
Q2 | $395K | Hold |
40,000
| – | – | 0.07% | 114 |
|
|
2016
Q1 | $676K | Buy |
+40,000
| New | +$643K | 0.12% | 103 |
|
Other funds holding ESPR
WA
TSC
PCM
ICM
